Literature DB >> 12005269

Is there a preferred triptan?

David W Dodick, Stephen Silberstein, Carl G H Dahlöf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12005269     DOI： 10.1046/j.1526-4610.2002.02001.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  5 in total

Review 1.  Eletriptan: a review of its use in the acute treatment of migraine.

Authors:  Paul L McCormack; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  The pharmacological management of migraine, part 1: overview and abortive therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-07

3.  Triptan partition in model membranes.

Authors:  Irene Wood; Mónica Pickholz
Journal:  J Mol Model       Date:  2014-09-24       Impact factor: 1.810

Review 4.  Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine.

Authors:  Janet D McEnroe; Joseph C Fleishaker
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

Review 5.  Why pharmacokinetic differences among oral triptans have little clinical importance: a comment.

Authors:  Anna Ferrari; Ilaria Tiraferri; Laura Neri; Emilio Sternieri
Journal:  J Headache Pain       Date:  2010-09-29       Impact factor: 7.277
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.